At the MedTech Conference, AdvaMed CEO Scott Whitaker outlined four policy priorities for the medical device industry: tariffs, FDA user fees, payment and coverage, and cybersecurity. The list signals where the trade group plans to focus its advocacy efforts as device makers navigate trade policy, regulatory funding, and reimbursement pressures.
Whitaker's emphasis on tariffs reflects ongoing industry worries about supply chain costs and trade barriers. On FDA user fees, the industry is looking ahead to the next reauthorization cycle, which determines how much companies pay the agency to review their products. Payment and coverage remains a perennial issue, as manufacturers seek predictable reimbursement pathways for new technologies.
The fourth priority, cybersecurity, underscores the growing importance of protecting connected medical devices from threats. The source, a report from MedCity News, presents these as the CEO's stated agenda, but does not provide details on specific proposals or timelines for each priority.